Amarin Corp. Plc (AMRN)
14.36
-0.12
(-0.83%)
USD |
NASDAQ |
Dec 12, 16:00
14.37
+0.01
(+0.07%)
After-Hours: 20:00
Amarin Research and Development Expense (TTM): 17.36M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Trinity Biotech Plc | 4.560M |
| Jazz Pharmaceuticals Plc | 809.33M |
| DBV Technologies SA | 95.77M |
| Cellectis SA | 70.72M |
| Akari Therapeutics Plc | 2.971M |